Perrigo (NYSE:PRGO) Stock Price Up 5.9% – Should You Buy?

Perrigo Company plc (NYSE:PRGO) rose 5.9% on Thursday. The stock traded as high as $14.28 and last traded at $14.6550. Approximately 164,126 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 3,073,148 shares. The stock had previously closed at $13.84.

Analyst Ratings Changes

A number of analysts have commented on the company. Weiss Ratings raised Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. Wall Street Zen upgraded Perrigo from a “buy” rating to a “strong-buy” rating in a report on Saturday, September 19th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.33.

Perrigo Trading Up 5.1%

The stock’s 50 day simple moving average is $13.03 and its two-hundred day simple moving average is $11.51. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. The stock has a market capitalization of $2.14 billion, a PE ratio of -1.23, a PEG ratio of 1.68 and a beta of 0.59.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.39 by $0.11. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.Perrigo’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, sell-side analysts expect that Perrigo Company plc will post 2.18 EPS for the current year.

Perrigo Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a dividend of $0.29 per share. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.16 annualized dividend and a yield of 7.5%. Perrigo’s dividend payout ratio is -9.27%.

Institutional Trading of Perrigo

A number of institutional investors have recently modified their holdings of the business. EverSource Wealth Advisors LLC grew its stake in Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock valued at $26,000 after buying an additional 1,014 shares in the last quarter. Huntington National Bank lifted its position in shares of Perrigo by 99.9% during the fourth quarter. Huntington National Bank now owns 4,741 shares of the company’s stock worth $66,000 after acquiring an additional 2,369 shares in the last quarter. KBC Group NV boosted its holdings in shares of Perrigo by 61.3% in the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock worth $67,000 after acquiring an additional 2,388 shares during the period. Parvin Asset Management LLC bought a new position in shares of Perrigo in the second quarter worth $79,000. Finally, Allworth Financial LP grew its position in shares of Perrigo by 489.1% in the second quarter. Allworth Financial LP now owns 9,390 shares of the company’s stock valued at $98,000 after purchasing an additional 7,796 shares in the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Perrigo Company Profile

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women’s health.

The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets.